article thumbnail

Government of Canada invests in clinical trial development in Canada through the Clinical Trials Fund

Pharma in Brief

On June 22, 2022, the Canadian Institutes of Health Research ( CIHR ) announced the launch of the Clinical Trials Fund ( CTF ), which will inject funding into Canada’s clinical trials environment. The Clinical Trials Fund. Clinical Trials Training Platforms ( CTTP ). Clinical Trials Projects.

article thumbnail

Reducing lung transplant rejection aim of clinical trial funded with $22 million grant

Scienmag

Physicians at Washington University School of Medicine in St.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy

pharmaphorum

Adding Eli Lilly’s rheumatoid arthritis drug Olumiant (baricitinib) and Gilead Sciences’ remdesivir reduces recovery time in COVID-19 patients compared to remdesivir alone, says a new trial. For now, analysis of the safety and mortality data from ACTT-2 are still ongoing, according to the president of Lilly Bio-Medicines, Patrik Jonsson.

Trials 110
article thumbnail

Oral immunotherapy induces remission of peanut allergy in some young children

Scienmag

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a daily oral dose of peanut flour for 2.5

article thumbnail

NIH expands clinical trials to test convalescent plasma against COVID-19

Scienmag

Rigorous studies to build on earlier efforts to test the experimental treatment Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19.

article thumbnail

New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue

The Pharma Data

15, 2021 — An inhaled medication might make every day physical activity a bit easier for patients with serious scarring of the lungs, a new clinical trial finds. 13 in the New England Journal of Medicine , involved patients with high blood pressure in the lungs caused by interstitial lung disease (ILD). FRIDAY, Jan.

Doctors 52
article thumbnail

£2 million secured to fuel expansion in early phase clinical trials  

Drug Discovery World

Integrated drug formulation and clinical trials company, BDD Clinical Trials, has secured a further round of investment for £2M to aid the company’s expansion in response to growing demand for both its patented drug delivery technology and specialist clinical trial services.